Literature DB >> 18225714

[Antibiotic resistance in Escherichia coli O157 isolated between 1998 and 2003 in The Netherlands].

H I J Roest1, E Liebana, W Wannet, Y van Duynhoven, K T Veldman, D J Mevius.   

Abstract

Little is known about the antibiotic resistance of E. coli O157 in The Netherlands. In this study, 218 human and 247 nonhuman samples, isolated between 1998 and 2003, were tested for antimicrobial resistance. About 5.5% of E. coli O157 isolates from human samples were resistant, as were about 4.00% of E. coli O157 isolates from non-human samples. These figures are lower than those reported in the literature. Class I integrons were found in six multiresistant isolates. This type of integron is also found in commensal E. coli in food animals and Salmonella spp. One of the integron-positive isolates contained the beta-lactamase bla(TEM-1b) and an extended spectrum beta-lactamase (ESBL), which belongs to the group 2 CTX-M enzymes. This is the first report of these beta-lactamases in E. coli O157 isolated from chicken.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18225714

Source DB:  PubMed          Journal:  Tijdschr Diergeneeskd        ISSN: 0040-7453


  8 in total

1.  Extended-spectrum-β-lactamase-producing Escherichia coli isolate possessing the Shiga toxin gene (stx1) belonging to the O64 serogroup associated with human disease in India.

Authors:  T K Dutta; Iadarilin Warjri; P Roychoudhury; H Lalzampuia; I Samanta; S N Joardar; S Bandyopadhyay; Rajesh Chandra
Journal:  J Clin Microbiol       Date:  2013-04-10       Impact factor: 5.948

2.  Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.

Authors:  Glenn Buvens; Pierre Bogaerts; Youri Glupczynski; Sabine Lauwers; Denis Piérard
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

3.  CTX-M-15 extended-spectrum β-lactamase in a shiga toxin-producing Escherichia coli isolate of serotype O111:H8.

Authors:  Charlotte Valat; Marisa Haenni; Estelle Saras; Frédéric Auvray; Karine Forest; Eric Oswald; Jean-Yves Madec
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

4.  Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.

Authors:  Glenn Buvens; Yves De Gheldre; Anne Dediste; Anne-Isabelle de Moreau; Georges Mascart; Anne Simon; Daniël Allemeersch; Flemming Scheutz; Sabine Lauwers; Denis Piérard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

5.  Phylogenetic grouping and virulence potential of extended-spectrum-β-lactamase-producing Escherichia coli strains in cattle.

Authors:  Charlotte Valat; Frédéric Auvray; Karine Forest; Véronique Métayer; Emilie Gay; Carine Peytavin de Garam; Jean-Yves Madec; Marisa Haenni
Journal:  Appl Environ Microbiol       Date:  2012-04-20       Impact factor: 4.792

6.  ESBL-producing Shiga-toxigenic E. coli (STEC) associated with piglet diarrhoea in India.

Authors:  Rajkumari Mandakini; Tapan Kumar Dutta; Santhalembi Chingtham; Parimal Roychoudhury; Indranil Samanta; Sidhartha Narayan Joardar; Abigail R Pachauau; Rajesh Chandra
Journal:  Trop Anim Health Prod       Date:  2014-12-04       Impact factor: 1.559

7.  Draft Genome Sequences of Enterohemorrhagic Escherichia coli Encoding Extended-Spectrum Beta-Lactamases.

Authors:  Charlotte Valat; Robert J Goldstone; Edouard Hirchaud; Marisa Haenni; David G E Smith; Jean-Yves Madec
Journal:  Genome Announc       Date:  2016-02-11

8.  Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, The Netherlands and Germany.

Authors:  Guanghui Wu; Michaela J Day; Muriel T Mafura; Javier Nunez-Garcia; Jackie J Fenner; Meenaxi Sharma; Alieda van Essen-Zandbergen; Irene Rodríguez; Cindy Dierikx; Kristina Kadlec; Anne-Kathrin Schink; Marie Chattaway; John Wain; Reiner Helmuth; Beatriz Guerra; Stefan Schwarz; John Threlfall; Martin J Woodward; Neil Woodford; Nick Coldham; Dik Mevius
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.